相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study
H. H. van der Zee et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Infliximab for Diabetic Macular Edema Refractory to Laser Photocoagulation A randomized, double-blind, placebo-controlled, crossover, 32-week study
Petros P. Sfikakis et al.
DIABETES CARE (2010)
Infliximab therapy for patients with moderate to severe hidradenitis, suppurativa: A randomized, double-blind, placebo-controlled crossover trial
Annika Grant et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Pyoderma gangrenosum: A review and update on new therapies
Jeremiah Miller et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Intravitreal Adalimumab for Refractory Uveitis-Related Macular Edema
Sofia Androudi et al.
OPHTHALMOLOGY (2010)
ADVERSE EVENTS AFTER INTRAVITREAL INFLIXIMAB (REMICADE)
Monica Giganti et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
Infliximab may be effective in the treatment of steroid-resistant eosinophilic fasciitis: report of three cases
Dinesh Khanna et al.
RHEUMATOLOGY (2010)
Treatment of Hidradenitis Suppurativa with Tumour Necrosis Factor-alpha Inhibitors
Pia Haslund et al.
ACTA DERMATO-VENEREOLOGICA (2009)
Neutrophilic Dermatoses A Review of Current Treatment Options
Philip R. Cohen
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2009)
Intravitreal Administration of the Anti-Tumor Necrosis Factor Agent Infliximab for Neovascular Age-related Macular Degeneration
Panagiotis G. Theodossiadis et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)
A Randomized, Double-blind, Placebo-controlled Study of Tumor Necrosis Factor-α Blockade in Severe Persistent Asthma
Sally E. Wenzel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis
C. P. Denton et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study
M. Rudwaleit et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Treatment of Refractory Ulcerative Necrobiosis Lipoidica Diabeticorum With Infliximab
Stephanie W. Hu et al.
ARCHIVES OF DERMATOLOGY (2009)
Idiopathic lobular panniculitis: remission induced and maintained with infliximab
F. Al-Niaimi et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Intravitreal administration of the anti-TNF monoclonal antibody Infliximab in the rabbit
Panagiotis G. Theodossiadis et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2009)
Evaluation of potential retinal toxicity of adalimumab (Humira)
Miltiadis Tsilimbaris et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2009)
Etanercept Treatment in Sweet's Syndrome with Inflammatory Arthritis
Nicola L. Ambrose et al.
JOURNAL OF RHEUMATOLOGY (2009)
A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa
Robert A. Lee et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Hidradenitis suppurativa: A comprehensive review
Ali Alikhan et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Inhibition of tumour necrosis factor alpha in idiopathic membranous nephropathy: a pilot study
Sofia Lionaki et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Effects of anti-TNF- antibody infliximab in refractory entero-Behets disease
Shigeru Iwata et al.
RHEUMATOLOGY (2009)
Adverse events and efficacy of TNF-α blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients
Martin Aringer et al.
RHEUMATOLOGY (2009)
Infliximab Effects Compared to Conventional Therapy in the Management of Retinal Vasculitis in Behcet Disease
Khalid F. Tabbara et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies
M. Dastmalchi et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
EULAR recommendations for the management of Behcet disease
G. Hatemi et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Infliximab for the treatment of neuro-Behcet's disease: A case series and review of the literature
Nicolo Pipitone et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor α-expressing cells
Hiroki Mitoma et al.
ARTHRITIS AND RHEUMATISM (2008)
Adult-onset Still's disease - Pathogenesis, clinical manifestations and therapeutic advances
Apostolos Kontzias et al.
DRUGS (2008)
Efficacy of infliximab for induction and maintenance of remission in intestinal Behcet's disease
Makoto Naganuma et al.
INFLAMMATORY BOWEL DISEASES (2008)
Infliximab monotherapy as adult-onset pityriasis rubra review of the literature first-line treatment for pilaris: Case report and on biologic therapy
Hansgeorg Mueller et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Effect of infliximab in progressive Neuro-Behcet's syndrome
Hirotoshi Kikuchi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Safety and efficacy of infliximab therapy in active Behcet's uveitis: an open-label trial
H. Al-Rayes et al.
RHEUMATOLOGY INTERNATIONAL (2008)
Ilium osteitis as the main manifestation of the SAPHO syndrome: Response to infliximab therapy and review of the literature
Concepcion Moll et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2008)
A pilot study on ocular safety of intravitreal infliximab in a rabbit model
Fabrizio Giansanti et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa
E. J. Giamarellos-Bourboulis et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review
N. Zeboulon et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Seronegative spondyloarthropathies and the eye
Amro Ali et al.
CURRENT OPINION IN OPHTHALMOLOGY (2007)
Do tumor necrosis factor inhibitors cause uveitis? A registry-based study
Lyndell L. Lim et al.
ARTHRITIS AND RHEUMATISM (2007)
Refractory retinal vasculitis due to sarcoidosis successfully treated with infliximab
Boris A. Cruz et al.
RHEUMATOLOGY INTERNATIONAL (2007)
Pulmonary aneurysms and intracardiac thrombi due to Behcet's disease in an African-American adolescent with oculocutaneous albinism
Lois M. Endo et al.
CLINICAL RHEUMATOLOGY (2007)
Successful treatment of life-threatening intestinal ulcer in Behcet's disease with infliximab: rapid healing of Behcet's ulcer with infliximab
Ji Hyeon Ju et al.
CLINICAL RHEUMATOLOGY (2007)
Infliximab therapy for the treatment of refractory ocular inflammatory disease
Lucia Sobrin et al.
ARCHIVES OF OPHTHALMOLOGY (2007)
Infliximab in the treatment of hepatic vein thrombosis (Budd-Chiari syndrome) in three patients with Behcet's syndrome
E. Seyahi et al.
RHEUMATOLOGY (2007)
Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study
L. Niccoli et al.
RHEUMATOLOGY (2007)
Infliximab in Takayasu arteritis: a safe alternative?
Zaharenia Th. Karageorgaki et al.
CLINICAL RHEUMATOLOGY (2007)
Anti-TNF therapy in the management of Behcet's disease - review and basis for recommendations
P. P. Sfikakis et al.
RHEUMATOLOGY (2007)
Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica - A randomized trial
Carlo Salvarani et al.
ANNALS OF INTERNAL MEDICINE (2007)
The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease
Stephen I. Rennard et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis - A randomized trial
Gary S. Hoffman et al.
ANNALS OF INTERNAL MEDICINE (2007)
Antitumor necrosis factor-α therapy for early postoperative recurrence of gastrointestinal Behcet's disease:: Report of a case
Jeong-Sik Byeon et al.
DISEASES OF THE COLON & RECTUM (2007)
Infliximab treatment for ocular and extraocular manifestations of Behcet's disease
Massimo Accorinti et al.
JAPANESE JOURNAL OF OPHTHALMOLOGY (2007)
Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis
Pirjo Tynjala et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Adalimumab in the therapy of uveitis in childhood
Sabine Biester et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2007)
Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis - A long-term followup study
R. K. Saurenmann et al.
ARTHRITIS AND RHEUMATISM (2007)
Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosus
Martin Aringer et al.
ARTHRITIS AND RHEUMATISM (2007)
Intravitreal infliximab and choroidal neovascularization in an animal model
Jeffrey L. Olson et al.
ARCHIVES OF OPHTHALMOLOGY (2007)
Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNFα agents
R. K. Saurenmann et al.
JOURNAL OF PEDIATRICS (2006)
Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study
S. Guignard et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
The treatment of disc herniation-induced sciatica with infliximab -: One-year follow-up results of FIRST II, a randomized controlled trial
Timo Korhonen et al.
SPINE (2006)
Characterization and outcome of uveitis in 350 patients with spondyloarthropathies
Percival D. Sampaio-Barros et al.
RHEUMATOLOGY INTERNATIONAL (2006)
Tumour necrosis factor α inhibitors in the treatment of childhood uveitis
R. K. Saurenmann et al.
RHEUMATOLOGY (2006)
Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial
TN Brooklyn et al.
GUT (2006)
The treatment of disc herniation-induced sciatica with infliximab -: Results of a randomized, controlled, 3-month follow-up study
T Korhonen et al.
SPINE (2005)
Randomized, double-blind, placebo-controlled trial of infliximab in patients with chronic pulmonary sarcoidosis
RP Baughman et al.
CHEST (2005)
Etanercept treatment for autoimmune inner ear disease: Results of a pilot placebo-controlled study
S Cohen et al.
OTOLOGY & NEUROTOLOGY (2005)
Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept
J Braun et al.
ARTHRITIS AND RHEUMATISM (2005)
Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behcet's disease -: An open-label trial
I Tugal-Tutkun et al.
ARTHRITIS AND RHEUMATISM (2005)
Long-term treatment of refractory posterior uveitis with anti-TNFα (infliximab)
JM Benitez-del-Castillo et al.
EYE (2005)
Etanercept for refractory ocular sarcoidosis - Results of a double-blind randomized trial
RP Baughman et al.
CHEST (2005)
A prospective trial of infliximab therapy for refractory uveitis - Preliminary safety and efficacy outcomes
EB Suhler et al.
ARCHIVES OF OPHTHALMOLOGY (2005)
Acute anterior uveitis and HLA-B27
JH Chang et al.
SURVEY OF OPHTHALMOLOGY (2005)
Therapeutic use of infliximab in sight threatening uveitis: retrospective analysis of efficacy, safety, and limiting factors
B Bodaghi et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Anti-TNF-α therapy for sight threatening uveitis
EW Lindstedt et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2005)
Regression of neovascular age-related macular degeneration following infliximab therapy
NN Markomichelakis et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2005)
A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis
JA Smith et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2005)
Regression of sight-threatening macular edema in type 2 diabetes following treatment with the anti-tumor necrosis factor monoclonal antibody infliximab
PP Sfikakis et al.
DIABETES CARE (2005)
Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey
M De Bandt et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Targeted anticytokine therapy in patients with chronic heart failure - Results of the Randomized Etanercept Worldwide evALuation (RENEWAL)
DL Mann et al.
CIRCULATION (2004)
Inefficacy of infliximab in primary Sjogren's syndrome -: Results of the randomized, controlled trial of Remicade in primary Sjogren's syndrome (TRIPSS)
X Mariette et al.
ARTHRITIS AND RHEUMATISM (2004)
Prospective study of TNFα blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis
A Booth et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Tumour necrosis factor a inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patients
C Pritchard et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients
A Kokkinos et al.
CLINICAL RHEUMATOLOGY (2004)
Safety and efficacy of tumor necrosis factor α blockade in systemic lupus erythematosus -: An open-label study
M Aringer et al.
ARTHRITIS AND RHEUMATISM (2004)
Treatment of multicentric reticulohistiocytosis with etanercept
BT Kovach et al.
ARCHIVES OF DERMATOLOGY (2004)
Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis
GS Hoffman et al.
ARTHRITIS AND RHEUMATISM (2004)
Pharmacokinetics and safety of intravitreally delivered etanercept
S Fauser et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2004)
Infliximab for chronic cystoid macular edema associated with uveitis
NN Markomichelakis et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2004)
Hidradenitis suppurativa associated with Crohn's disease and spondyloarthropathy: response to anti-TNF therapy
M Roussomoustakaki et al.
JOURNAL OF GASTROENTEROLOGY (2003)
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure -: Results of the Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial
ES Chung et al.
CIRCULATION (2003)
Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis
Y El-Shabrawi et al.
OPHTHALMOLOGY (2002)
Efficacy of the anti-TNF-α antibody infliximab against refractory systemic vasculitides:: an open pilot study on 10 patients
P Bartolucci et al.
RHEUMATOLOGY (2002)
Sustained response to tumor necrosis factor α-blocking agents in two patients with SAPHO syndrome
AD Wagner et al.
ARTHRITIS AND RHEUMATISM (2002)
Treatment of intestinal Behcet's syndrome with chimeric tumour necrosis factor α antibody
SPL Travis et al.
GUT (2001)
Hidradenitis suppurativa and Crohn's disease:: Response to treatment with infliximab
F Martínez et al.
INFLAMMATORY BOWEL DISEASES (2001)
分享论文
